Overall concordance on review type was 74.8%.kwas 0.47 indicating moderate agreement. Agreement on review type was>70% for all drugs, except oncology therapies
Overall concordance onreview type was 74.8%.kwas 0.47 indicating moderate agreement. Agreement on review type was>70%for all drugs, except oncology therapies